KR101501889B1 - 저용량 라모세트론 함유 구강 내 붕괴정 - Google Patents
저용량 라모세트론 함유 구강 내 붕괴정 Download PDFInfo
- Publication number
- KR101501889B1 KR101501889B1 KR1020147010720A KR20147010720A KR101501889B1 KR 101501889 B1 KR101501889 B1 KR 101501889B1 KR 1020147010720 A KR1020147010720 A KR 1020147010720A KR 20147010720 A KR20147010720 A KR 20147010720A KR 101501889 B1 KR101501889 B1 KR 101501889B1
- Authority
- KR
- South Korea
- Prior art keywords
- ramosetron
- disintegrating tablet
- hydrochloride
- pharmaceutically acceptable
- acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011237240 | 2011-10-28 | ||
JPJP-P-2011-237240 | 2011-10-28 | ||
PCT/JP2012/077687 WO2013062073A1 (ja) | 2011-10-28 | 2012-10-26 | 低用量ラモセトロン含有口腔内崩壊錠 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140081829A KR20140081829A (ko) | 2014-07-01 |
KR101501889B1 true KR101501889B1 (ko) | 2015-03-12 |
Family
ID=48167898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020147010720A KR101501889B1 (ko) | 2011-10-28 | 2012-10-26 | 저용량 라모세트론 함유 구강 내 붕괴정 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5365949B2 (ja) |
KR (1) | KR101501889B1 (ja) |
WO (1) | WO2013062073A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5984320B2 (ja) * | 2014-05-26 | 2016-09-06 | 大原薬品工業株式会社 | ホリナートカルシウム含有フィルムコーティング錠 |
JP6768309B2 (ja) * | 2015-04-28 | 2020-10-14 | 大原薬品工業株式会社 | 光安定性を向上したシロドシン含有着色錠剤 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2807346B2 (ja) * | 1991-12-24 | 1998-10-08 | 山之内製薬株式会社 | 口腔内崩壊製剤及びその製造法 |
JP2005213244A (ja) * | 2004-01-30 | 2005-08-11 | Astellas Pharma Inc | 下痢型過敏性腸症候群治療剤 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2983973B1 (ja) * | 1998-10-13 | 1999-11-29 | 大正薬品工業株式会社 | 口腔内速崩壊性固形製剤 |
JP2002138055A (ja) * | 2000-10-31 | 2002-05-14 | Nipro Corp | 口腔内速崩壊性圧縮成型物およびその製造方法 |
-
2012
- 2012-10-26 WO PCT/JP2012/077687 patent/WO2013062073A1/ja active Application Filing
- 2012-10-26 JP JP2013505264A patent/JP5365949B2/ja active Active
- 2012-10-26 KR KR1020147010720A patent/KR101501889B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2807346B2 (ja) * | 1991-12-24 | 1998-10-08 | 山之内製薬株式会社 | 口腔内崩壊製剤及びその製造法 |
JP2005213244A (ja) * | 2004-01-30 | 2005-08-11 | Astellas Pharma Inc | 下痢型過敏性腸症候群治療剤 |
Also Published As
Publication number | Publication date |
---|---|
WO2013062073A1 (ja) | 2013-05-02 |
JPWO2013062073A1 (ja) | 2015-04-02 |
KR20140081829A (ko) | 2014-07-01 |
JP5365949B2 (ja) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6545839B2 (ja) | 口腔内崩壊錠及びその製造方法 | |
JP4707073B2 (ja) | アトルバスタチン経口投与用粒子状医薬組成物 | |
JP5296456B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP7096164B2 (ja) | ジアミン誘導体を含む口腔内崩壊錠 | |
KR20130030306A (ko) | 약학 조성물 | |
KR101479824B1 (ko) | 용출 안정성 제제 | |
JP5974469B2 (ja) | 錠剤の製造方法 | |
Parmar et al. | Co-processing of small molecule excipients with polymers to improve functionality | |
JP5134802B2 (ja) | 塩酸ブロムヘキシン含有量低下の防止方法 | |
JP2013533881A (ja) | バノキセリンを含有する医薬組成物 | |
KR101501889B1 (ko) | 저용량 라모세트론 함유 구강 내 붕괴정 | |
JP5978335B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
TWI762450B (zh) | 超高速崩解錠劑及其製造方法 | |
JP2008127320A (ja) | 口腔内速崩壊性固形製剤 | |
WO2012042951A1 (ja) | アトルバスタチン含有医薬錠剤 | |
US8741344B1 (en) | Dispersible tablet | |
JP7250305B2 (ja) | メマンチン又はその薬物学的に許容される塩を含む医薬組成物及びその製造方法 | |
KR20140076998A (ko) | 에스오메프라졸 유리염기 또는 그의 알칼리염을 포함하는 고미가 차폐된 약학 제제 및 이의 제조방법 | |
WO2009128489A1 (ja) | 塩酸バンコマイシンを含有する錠剤 | |
WO2014171307A1 (ja) | 小児への投与に適した速崩壊錠とその簡便な製造方法 | |
JP5714652B2 (ja) | 溶出が良好なイルベサルタン含有医薬組成物および口腔内崩壊錠 | |
JP4658306B2 (ja) | 錠剤用医薬組成物 | |
DK177906B1 (en) | Dispersible tablet | |
WO2014171306A1 (ja) | 小動物への投与に適した速崩壊錠とその簡便な製造方法 | |
CN115803020A (zh) | 含有苯磺酸米洛巴林的口腔崩解片剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20180219 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20200218 Year of fee payment: 6 |